Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 623 INR -0.25% Market Closed
Market Cap: 327.6B INR

Intrinsic Value

The intrinsic value of one AJANTPHARM stock under the Base Case scenario is 1 914.75 INR. Compared to the current market price of 2 623 INR, Ajanta Pharma Ltd is Overvalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AJANTPHARM Intrinsic Value
1 914.75 INR
Overvaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ajanta Pharma Ltd

AJANTPHARM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AJANTPHARM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Ajanta Pharma Ltd
NSE:AJANTPHARM
IN
Pharmaceuticals
Market Cap
327.6B INR
IPO
Jun 5, 2000
IN
Pharmaceuticals
Market Cap
327.6B INR
IPO
Jun 5, 2000
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AJANTPHARM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Ajanta Pharma Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ajanta Pharma Ltd

Current Assets 27.9B
Cash & Short-Term Investments 7.6B
Receivables 10.4B
Other Current Assets 9.9B
Non-Current Assets 20B
Long-Term Investments 340m
PP&E 17.9B
Intangibles 133.2m
Other Non-Current Assets 1.7B
Efficiency

Free Cash Flow Analysis
Ajanta Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ajanta Pharma Ltd

Revenue
45.3B INR
Cost of Revenue
-10.5B INR
Gross Profit
34.8B INR
Operating Expenses
-23.5B INR
Operating Income
11.3B INR
Other Expenses
-2.3B INR
Net Income
9B INR
Fundamental Scores

AJANTPHARM Profitability Score
Profitability Due Diligence

Ajanta Pharma Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
67/100
Profitability
Score

Ajanta Pharma Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

AJANTPHARM Solvency Score
Solvency Due Diligence

Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
97/100
Solvency
Score

Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AJANTPHARM Price Targets Summary
Ajanta Pharma Ltd

Wall Street analysts forecast AJANTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AJANTPHARM is 2 961.57 INR with a low forecast of 2 000.81 INR and a high forecast of 3 739.05 INR.

Lowest
Price Target
2 000.81 INR
24% Downside
Average
Price Target
2 961.57 INR
13% Upside
Highest
Price Target
3 739.05 INR
43% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AJANTPHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AJANTPHARM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AJANTPHARM stock?

The intrinsic value of one AJANTPHARM stock under the Base Case scenario is 1 914.75 INR.

Is AJANTPHARM stock undervalued or overvalued?

Compared to the current market price of 2 623 INR, Ajanta Pharma Ltd is Overvalued by 27%.

Back to Top